
Journal of Organometallic Chemistry p. 171 - 180 (1997)
Update date:2022-08-03
Topics:
Vila, Jose M.
Gayoso, Miguel
Pereira, Ma Teresa
Torres, Margarita Lopez
Fernandez, Jesus J.
Fernandez, Alberto
Ortigueira, Juan M.
Treatment of N-(2-chlorobenzylidene)-N,N′-dimethylethylenediamine, 2-ClC6H4C(H)=NCH2CH2NMe2, with tris(dibenzylideneacetone)dipalladium(0) in chloroform gave the oxidative addition cyclometallated product [Pd{C6H4C(H)=NCH2CH2NMe2}(Cl)] (1) with the palladium atom bonded to a C,N,N′ terdentate donor ligand. Treatment of 1 with tertiary monophosphines gave the cyclometallated complexes [Pd{C6H4C(H)=NCH2CH2NMe2}(Cl(L)] (2: L = PPh3; 3: L = PEtPh2; 4: L = PEt2Ph; 5: L = PEt3), where the phosphine ligand is either trans to the phenyl carbon atom (2, 3) or trans to the imine nitrogen atom (4, 5). Treatment of 1 with silver perchlorate followed by reaction with tertiary monophosphines gave the cyclometallated complexes [Pd{C6H4C(H)=N-CH2CH2NMe2}(L)][ClO4] (6: L = PPh3; 7: L = PEtPh2; 8: L = PEt2Ph; 9: L = PEt3). Reaction of 1 with thallium acetylacetonate gave the cyclometallated complex [Pd{C6H4C(H)=NCH2CH2NMe2}(H3CCOCHCOCH3)] (10). Treatment of 1 with ditertiary diphosphines in a complex 1/diphosphine 2:1 molar ratio gave the dinuclear cyclometallated complexes [{Pd[C6H4C(H)=NCH2CH2NMe2](Cl)}2(L-L)] (11: L-L = trans-Ph2PCH=CHP-Ph2; 12: L-L = Ph2P(CH2)3PPh2; 13: L-L = Ph2P(CH2)4PPh2), where the phosphorus atom is trans to the phenyl carbon atom. Treatment of 1 with silver perchlorate followed by ditertiary diphosphines in a complex 1/diphosphine 2:1 molar ratio gave the dinuclear cyclometallated complexes [{Pd[C6H4C(H)=NCH2CH2NMe2]}2(L-L)][ClO4]2 [14: L-L = trans-Ph2P-CH=CHPPh2; 15: L-L = Ph2P(CH2)3PPh2; 16: L-L = Ph2P(CH2)4PPh2)]. Reaction of 1 with ditertiary diphosphines in a complex 1/diphosphine 1:1 molar ratio, and silver perchlorate as appropriate, gave the cyclometallated complexes [Pd{C6H4C(H)=NCH2CH2NMe2}(Ph2P(CH2)2PPh2-P,P)][ClO4] (17), [Pd{C6H4C(H)=NCH2CH2NMe2}(Ph2P(CH2)3PPh2-P,P)][ClO4] (18), [Pd{C6H4C(H)=NCH2CH2NMe2}(cis-Ph2PCH = CHPPh2-P,P)][Cl] (19) and [Pd{C6H4C-(H)=NCR2CH2NMe2}(Cl)(Ph2P(CH2)4PPh2-P,P)] (20).
View MoreContact:+86-21-61318535
Address:Building 29,No.2139 Xizha Road, Fengxian District, Shanghai
Xinjiang Fufeng Biotechnologies Co., Ltd.
Contact:+86-539-7287111
Address:GANQUANPU INDUSTRIAL PARK, ECONOMIC AND TECHNOLOGICAL DEVELOPMENT AREA (TOUTUNHE DISTRICT) OF URUMQI
Contact:0510-85393305
Address:1619 Huishan Avenue, Huishan District, Wuxi,
Chengdu Sino-Strong Pharmaceutical Co.,Ltd.
website:http://www.sino-strong.com.cn
Contact:+86-28-82666753
Address:459 West haike road,Cross-straits technological industry park, Wenjiang district,Chengdu, P.R.China
Beyond Pharmaceutical Co., Ltd
Contact:+86-571-8195-3185
Address:No. 13-1, Liansheng Road, Yuhang District
Doi:10.1016/S0040-4039(97)00757-0
(1997)Doi:10.1002/hlca.19970800308
(1997)Doi:10.1002/anie.199711101
(1997)Doi:10.1080/07328319708001356
(1997)Doi:10.1007/BF00766097
()Doi:10.1016/S0957-4166(97)00222-X
(1997)